08/20/2024 | Press release | Archived content
Date: 08/20/24
Cahill represented the lead arranger and bookrunners in connection with an AUD $200 million incremental term B credit facility and an AUD $100 million incremental delayed draw term B credit facility for APOG Bidco Pty Ltd (d/b/a Icon Group).
Proceeds from the drawn credit facility were used to finance the acquisition of Qualasept Holdings Limited (d/b/a Pharmaxo Group), to repay existing indebtedness, and to pay related transaction expenses. Proceeds from the delayed draw credit facility will be used for general corporate purposes.
APOG Bidco Pty Ltd is an Australian private company that provides health care services.